SNDX
Price
$15.84
Change
+$0.29 (+1.86%)
Updated
Sep 15 closing price
Capitalization
1.36B
56 days until earnings call
WHWK
Price
$1.86
Change
-$0.13 (-6.53%)
Updated
Sep 15 closing price
Capitalization
87.66M
50 days until earnings call
Interact to see
Advertisement

SNDX vs WHWK

Header iconSNDX vs WHWK Comparison
Open Charts SNDX vs WHWKBanner chart's image
Syndax Pharmaceuticals
Price$15.84
Change+$0.29 (+1.86%)
Volume$2.08M
Capitalization1.36B
Whitehawk Therapeutics
Price$1.86
Change-$0.13 (-6.53%)
Volume$105.69K
Capitalization87.66M
SNDX vs WHWK Comparison Chart in %
Loading...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WHWK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SNDX vs. WHWK commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNDX is a Hold and WHWK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 16, 2025
Stock price -- (SNDX: $15.84 vs. WHWK: $1.86)
Brand notoriety: SNDX and WHWK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SNDX: 88% vs. WHWK: 101%
Market capitalization -- SNDX: $1.36B vs. WHWK: $87.66M
SNDX [@Biotechnology] is valued at $1.36B. WHWK’s [@Biotechnology] market capitalization is $87.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.82B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNDX’s FA Score shows that 1 FA rating(s) are green whileWHWK’s FA Score has 0 green FA rating(s).

  • SNDX’s FA Score: 1 green, 4 red.
  • WHWK’s FA Score: 0 green, 5 red.
According to our system of comparison, WHWK is a better buy in the long-term than SNDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNDX’s TA Score shows that 4 TA indicator(s) are bullish while WHWK’s TA Score has 5 bullish TA indicator(s).

  • SNDX’s TA Score: 4 bullish, 5 bearish.
  • WHWK’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, WHWK is a better buy in the short-term than SNDX.

Price Growth

SNDX (@Biotechnology) experienced а -3.00% price change this week, while WHWK (@Biotechnology) price change was +3.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.37%. For the same industry, the average monthly price growth was +6.67%, and the average quarterly price growth was +33.69%.

Reported Earning Dates

SNDX is expected to report earnings on Nov 11, 2025.

WHWK is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNDX($1.36B) has a higher market cap than WHWK($87.7M). SNDX YTD gains are higher at: 19.818 vs. WHWK (-41.046). WHWK has higher annual earnings (EBITDA): -10.21M vs. SNDX (-314.25M). SNDX has more cash in the bank: 469M vs. WHWK (177M). WHWK has less debt than SNDX: WHWK (0) vs SNDX (1.68M). SNDX has higher revenues than WHWK: SNDX (77.9M) vs WHWK (21.6M).
SNDXWHWKSNDX / WHWK
Capitalization1.36B87.7M1,555%
EBITDA-314.25M-10.21M3,077%
Gain YTD19.818-41.046-48%
P/E RatioN/A11.67-
Revenue77.9M21.6M361%
Total Cash469M177M265%
Total Debt1.68M0-
FUNDAMENTALS RATINGS
SNDX vs WHWK: Fundamental Ratings
SNDX
WHWK
OUTLOOK RATING
1..100
8518
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
38
Fair valued
PROFIT vs RISK RATING
1..100
10098
SMR RATING
1..100
9995
PRICE GROWTH RATING
1..100
4249
P/E GROWTH RATING
1..100
543
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WHWK's Valuation (38) in the Pharmaceuticals Major industry is somewhat better than the same rating for SNDX (84) in the Biotechnology industry. This means that WHWK’s stock grew somewhat faster than SNDX’s over the last 12 months.

WHWK's Profit vs Risk Rating (98) in the Pharmaceuticals Major industry is in the same range as SNDX (100) in the Biotechnology industry. This means that WHWK’s stock grew similarly to SNDX’s over the last 12 months.

WHWK's SMR Rating (95) in the Pharmaceuticals Major industry is in the same range as SNDX (99) in the Biotechnology industry. This means that WHWK’s stock grew similarly to SNDX’s over the last 12 months.

SNDX's Price Growth Rating (42) in the Biotechnology industry is in the same range as WHWK (49) in the Pharmaceuticals Major industry. This means that SNDX’s stock grew similarly to WHWK’s over the last 12 months.

SNDX's P/E Growth Rating (5) in the Biotechnology industry is somewhat better than the same rating for WHWK (43) in the Pharmaceuticals Major industry. This means that SNDX’s stock grew somewhat faster than WHWK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SNDXWHWK
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 11 days ago
83%
Bullish Trend 14 days ago
78%
Declines
ODDS (%)
Bearish Trend 6 days ago
77%
Bearish Trend 1 day ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
79%
Aroon
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WHWK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CPAMF1.84N/A
N/A
CAPITALAND INTEGRATED COML TR MGMT LTD
HRBR0.50N/A
N/A
Harbor Diversified, Inc.
RTON0.02N/A
N/A
Right On Brands, Inc.
SEIGY3.70N/A
N/A
Semperit Ag Holding
BVNRY12.16-0.02
-0.16%
Bavarian Nordic A/S

SNDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDX has been loosely correlated with REPL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SNDX jumps, then REPL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDX
1D Price
Change %
SNDX100%
+1.86%
REPL - SNDX
51%
Loosely correlated
-1.05%
CGON - SNDX
49%
Loosely correlated
+3.78%
ETNB - SNDX
48%
Loosely correlated
-0.62%
XENE - SNDX
47%
Loosely correlated
-0.61%
NRIX - SNDX
47%
Loosely correlated
-4.09%
More

WHWK and

Correlation & Price change

A.I.dvisor indicates that over the last year, WHWK has been loosely correlated with DMAC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if WHWK jumps, then DMAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WHWK
1D Price
Change %
WHWK100%
-6.53%
DMAC - WHWK
45%
Loosely correlated
-1.13%
AXON - WHWK
44%
Loosely correlated
+0.62%
AMRN - WHWK
37%
Loosely correlated
-0.53%
ARRY - WHWK
36%
Loosely correlated
+1.83%
SNDX - WHWK
34%
Loosely correlated
+1.86%
More